Seaport Therapeutics’ IPO aims to fund prodrug R&D for neuropsychiatric disorders. Read the full analysis here.

Investors have watched AI reshape one industry after another. Now Anthropic’s latest move has software-as-a-service (SaaS) ...

Record loan originations and a scaling tokenized credit platform are strengthening Figure’s growth outlook, even as shares lag broader digital asset markets, according to Bernstein.

NVIDIA (NVDA) stands at a pivotal moment, potentially representing a 'Liberation Day' 2025 valuation on a fundamental basis.

Energy drinks are a billion dollar industry, but how many actually know what happens inside your body when you drink one?

Police have charged a 37-year-old man with murder after officers attending a remote Tablelands property for a welfare check ...

Researchers found that a bacterium from kimchi can bind and help expel nanoplastics from the body, showing promise as a ...

Investing.com - Bernstein SocGen Group lowered its price target on Figure Technology (NASDAQ:FIGR) to $67 from $72 while maintaining an Outperform rating on the shares. The stock currently trades at ...

R3 Bio, a billionaire-backed biotech startup, is committed to designing “complete organ systems” to be used for scientific testing.

Figure Technology Solutions (NASDAQ:FIGR) Chief Capital Officer David Todd Stevens sold a total of 49,608 shares of Class A Common Stock on March 19, 2026, for approximately $1.59 million.

Investors obviously didn't figure a significant bottom-line miss was in the cards for Figure Technology Solutions' (NASDAQ: FIGR) final quarter of 2025. That's a key reason they traded out of the next ...

The fintech's fourth-quarter bottom line wasn't nearly as high as the market expected. It did, however, post significant gains in both revenue and profitability. Figure, which harnesses blockchain ...